OrbiMed’s X4 Pharmaceuticals XFOR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,776,515	Closed	-$1.6M	–	118
2025 Q1	$1.6M	Sell	6,776,515 -357,000	-5%	-$84.4K	0.04%	91
2024 Q4	$5.23M	Hold	7,133,515	–	–	0.11%	83
2024 Q3	$4.77M	Hold	7,133,515	–	–	0.09%	95
2024 Q2	$4.14M	Hold	7,133,515	–	–	0.08%	92
2024 Q1	$9.92M	Hold	7,133,515	–	–	0.18%	81
2023 Q4	$5.98M	Hold	7,133,515	–	–	0.12%	87
2023 Q3	$7.78M	Hold	7,133,515	–	–	0.17%	88
2023 Q2	$13.8M	Buy	7,133,515 +1,315,789	+23%	+$2.55M	0.25%	77
2023 Q1	$5.06M	Hold	5,817,726	–	–	0.1%	99
2022 Q4	$5.78M	Buy	5,817,726 +790,909	+16%	+$785K	0.11%	91
2022 Q3	$8.6K	Buy	5,026,817 +3,652,968	+266%	+$6.25K	0.16%	89
2022 Q2	$1.33K	Hold	1,373,849	–	–	0.02%	132
2022 Q1	$2.4M	Hold	1,373,849	–	–	0.04%	129
2021 Q4	$3.15M	Hold	1,373,849	–	–	0.04%	144
2021 Q3	$7.27M	Hold	1,373,849	–	–	0.08%	142
2021 Q2	$8.93M	Hold	1,373,849	–	–	0.09%	129
2021 Q1	$11.8M	Buy	1,373,849 +287,356	+26%	+$2.47M	0.11%	116
2020 Q4	$6.99M	Hold	1,086,493	–	–	0.06%	134
2020 Q3	$7.36M	Hold	1,086,493	–	–	0.09%	115
2020 Q2	$10.1M	Hold	1,086,493	–	–	0.14%	98
2020 Q1	$10.9M	Hold	1,086,493	–	–	0.18%	81
2019 Q4	$11.6M	Buy	1,086,493 +150,000	+16%	+$1.6M	0.17%	79
2019 Q3	$11.9M	Hold	936,493	–	–	0.23%	75
2019 Q2	$14M	Buy	936,493 +625,000	+201%	+$9.37M	0.22%	78
2019 Q1	$5.42M	Sell	311,493 -1,557,473	-83%	-$27.1M	0.08%	99
2018 Q4	$4.34M	Hold	1,868,966	–	–	0.08%	99
2018 Q3	$3.03M	Hold	1,868,966	–	–	0.04%	134
2018 Q2	$6.78M	Hold	1,868,966	–	–	0.08%	120
2018 Q1	$42.8M	Hold	1,868,966	–	–	0.53%	54
2017 Q4	$23.8M	Buy	+1,868,966	New	+$23.8M	0.3%	73